Kuhajda FP, Ronnett GV: Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity
I mean, theyve had him try low dose naltrexone
Studies have shown that patients on these medications, combined with lifestyle changes, can achieve substantial weight loss, often in the range of 15% to over 20% of their total body weight, making them a powerful tool in the fight against obesity
Its influence on reward circuits, satiety, and emotional regulation suggests wider potential for understanding neuroendocrine integration and behavioral modulation mechanisms
This complexity underscores the need for stage-specific interventions: acute mitochondrial injury may respond to antioxidants or metabolic substrates, while advanced disease may require reprogramming of cellular bioenergetics